SCHEMBL7413229

SCHEMBL7413229

CCCCCCCCc1cc(N)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.47
TSHR P16473 2/20 0.46
MEN1 O00255 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
ALOX5 P09917 1/20 0.46
MAPT P10636 1/20 0.46
TYR P14679 1/20 0.46
ALOX15 P16050 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TLR8 Q9NR97 12/20 0.44
GPR84 Q9NQS5 1/20 0.42
SRC P12931 1/20 0.42
SPHK2 Q9NRA0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8589749 0.98 TLR8 (0.45) HTR2ATSHRMEN1TP53CYP3A4
SCHEMBL13529189 0.93 TLR8 (0.44) HTR2ATSHRMEN1TP53CYP3A4
SCHEMBL22914584 0.86 TYR (0.50) HTR2ATSHRMEN1TP53CYP3A4
SCHEMBL17190848 0.85 PRKCI (0.40) TSHRMEN1TP53MAPTHTT
SCHEMBL10345219 0.81 HTR2A (0.46) HTR2ATSHRMEN1TP53CYP3A4
SCHEMBL21392022 0.81 ALOX5 (0.49) HTR2ATSHRMEN1TP53CYP3A4
SCHEMBL12798389 0.81 HTR2A (0.46) HTR2ATSHRMEN1TP53CYP3A4
SCHEMBL207523 0.81 HTR2A (0.46) HTR2ATSHRMEN1TP53CYP3A4
SCHEMBL5377545 0.81 MAPT (0.49) HTR2ATSHRMEN1TP53CYP3A4
SCHEMBL2018932 0.81 HTR2A (0.46) HTR2ATSHRMEN1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003740-A2 PYRROLIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGOISTS Abbott Laboratories (US) 2000-05-31 EP disclosed
WO-1999006397-A2 PYRROLIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ABBOTT LABORATORIES (US) 1999-02-11 WO disclosed